Make a donation that could change someone’s life to the bone marrow and cancer foundation. The Bone Marrow & Cancer Foundation supports patients, their families, and caregivers every step of the way during a cancer diagnosis or bone marrow, Hematopoietic Cell Transplantation (HCT), or cord blood transplant. No patient should ever feel alone.
The Bone Marrow & Cancer Foundation relies 100% on private donations. Your generous tax-deductible contribution will help us meet the needs of critically ill cancer and transplant patients and their families. Thank you for your support.
Diamond Blackfan Anemia (DBA) was first recognized as a distinct entity in 1938, although it was called “congenital hypoplastic anemia” at that time. Diamond Blackfan Anemia (“DBA”) is a rare inherited bone marrow failure syndrome, characterized by a failure of the bone marrow (the center of the bone where blood cells are made) to produce red blood cells. This failure causes DBA patients to become severely anemic. It is important to note that this anemia is not the result of a deficiency in iron, vitamin B-12, folate, or erythropoietin, which is a blood cell stimulating factor. Although a number of theories regarding the cause of DBA have been proposed, it is now widely accepted that DBA is a ribosomal protein disease. The disorder results from an intrinsic progenitor cell defect in which erythroid progenitors and precursors are highly sensitive to death by apoptosis (self-destruction).